Real-time enrollment status for this metastatic breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT04039230 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | August 6, 2025 (Aug 6, 2025) |
As of March 2, 2026: Clinical trial NCT04039230 is currently recruiting participants. This clinical trial study for metastatic breast cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04039230 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04039230 was last updated Aug 6, 2025 (August 6, 2025). HelloStudys verifies this status automatically.